GlassScriptPhysician profile
Roshan P Shah
NPI 1245438928
$1,316,323.68
in general payments reported to CMS, 2019-2025
17 companies · $866K in 2025
The $866K reported for 2025 was more than what 98% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $14K · 2021: $26K · 2022: $49K · 2023: $86K · 2024: $235K · 2025: $866K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.1M · Education: $79K · Travel and Lodging: $25K · Food and Beverage: $8,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,073,797.06 |
| Education | $78,711.78 |
| Travel and Lodging | $25,325.54 |
| Food and Beverage | $8,938.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,172,384.56 | 2019-2025 | Persona, Rosa, Arcos |
| Linkbio Corp | $95,251.58 | 2019-2025 | |
| Ethicon US, LLC | $21,034.47 | 2019-2025 | Stratafix, Harmonic, Dermabond |
| Medical Device Business Services, INC. | $14,118.46 | 2019-2024 | |
| Depuy Synthes Products, INC. | $7,257.80 | 2019 | |
| Stryker Corporation | $2,956.13 | 2019-2025 | Mako |
| Ethicon INC. | $1,650.00 | 2020-2022 | |
| Smith+Nephew, INC. | $522.04 | 2019-2024 | Redapt, Hip7 |
| Depuy Synthes Sales INC. | $459.21 | 2019-2025 | Va-Lcp |
| Davol INC. | $247.39 | 2024-2025 | Arista, Surgiphor, Channel Drain |
| Horizon Therapeutics Plc | $141.73 | 2019 | |
| Microport Orthopedics INC | $129.55 | 2019 | |
| Heron Therapeutics, INC. | $120.76 | 2025 | Zynrelef |
| Pacira Therapeutics, INC. | $50.00 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.